Altre lingue bioAffinity Technologies, Inc.

Azioni

BIAF

US09076W1099

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
2,37 ^USD	-1,66%		-14,75%	+61,17%

01/04	BioAffinity Technologies, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
08/03	BioAffinity Technologies chiude un'offerta azionaria da 2,5 milioni di dollari	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth	24/04
BioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening	09/04
BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
BioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results	01/04
BioAffinity Technologies, Inc. announced that it has received $2.624 million in funding	20/03
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	11/03
BioAffinity Technologies Closes $2.5 Million Equity Offerings	08/03
Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement	08/03
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	08/03
WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement	06/03
BioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	06/03
BioAffinity Technologies Reports Accelerating Sales Growth of CyPath Lung	06/03
BioAffinity Technologies, Inc. announced that it expects to receive $2.624 million in funding	06/03
BioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung	05/03
BioAffinity Technologies News Update	21/02
Medical Director of Pennsylvania's Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies Medical and Scientific Advisory Board and Incorporates CyPath Lung into Medical Practice	07/02
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice	06/02
BioAffinity Technologies, Inc. Appoints Sandeep Bansal to Medical and Scientific Advisory Board	06/02
BioAffinity Technologies In The News	30/01
BioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer	23/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue bioAffinity Technologies, Inc.

Azioni

BIAF

US09076W1099

Altre lingue

Filtri